Investigator
Initiated Extended Clinical Trial (R01)
Funding Opportunity Announcement (FOA) Number: PAR-17-056
Funding Opportunity Purpose
This
Funding Opportunity Announcement (FOA) invites applications for implementation
of investigator-initiated clinical trials requiring an extended project period
of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and
related to the research mission of one of the participating ICs. Consultation
with IC staff is strongly encouraged prior to the submission of the clinical
trial implementation application. This FOA is not intended for support of
clinical trials that do not require an extended project period of 6 or 7
years.
Key Dates
Open Date (Earliest Submission Date): February 7, 2017
Letter of Intent Due Date(s): 30 days before
application due date
Application Due Date(s): March
7, 2017; December 7, 2017; by 5:00 PM local time of applicant organization. Applicants are
encouraged to apply early to allow adequate time to make any corrections to
errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
March
7, 2017; December 7, 2017, by 5:00 PM local time of applicant organization. All
types of AIDS
and AIDS-related applications allowed for this funding opportunity
announcement are due on these dates.
Applicants are
encouraged to apply early to allow adequate time to make any corrections to
errors found in the application during the submission process by the due date.
Scientific Merit Review: June 2017
Advisory Council Review: August 2017
Earliest Start Date: September 2017
